Genomics

Edited By Louis Marie | 5/26/2020

Read Download Book Description: Title: - [(Rabbit Biotechnology : Rabbit Genomics , Transgenesis, Cloning and Models)] [Edited by Louis Marie Houdebine ] published on (October, 2010) by Louis Marie Houdebine Author: Louis Marie Houdebine. 3b68cf911f243b1f1b9d735bd5184d0f Recent Member Activity Loading… [(Rabbit Biotechnology : Rabbit Genomics , Transgenesis, Cloning and Models)] [Edited by Louis Marie Houdebine ] published on (October, 2010) by Louis Marie Houdebine …

Analysts’ Downgrades for May, 25th (CGBD, CGEN, CHA, CHL, CHT, CHYCY, CLPHY, CLSK, CLUB, CPF) | 5/26/2020

… Inc alerts: Compugen (NASDAQ:CGEN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen’s expertise in these areas is …

Follow Genomics:    

NIBMG BioMedical Genomics Integrated MS-PhD program 2020 Admissions Open | 5/26/2020

http://www.helpbiotech.co.in/2020/05/nibmg-biomedical-genomics-integrated-ms.html …

Eagle Genomics and Cargill agree on microbiome research collaboration | 5/26/2020

UK-based microbiome firm Eagle Genomics is to enter into a pact with Cargill as part of a multi-year deal looking to harness artificial intelligence (AI) to the agricultural commodity giant’s microbiome and life sciences R&D. The deal will use Eagle Genomics’ ‘e[datascientist],’ a platform that utilises machine learning to make novel connections concealed within a wealth of microbiome and genomics data. According to the firm, the …

Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope In Situ Hybridization Detection Kit | PR Newswire | 5/26/2020

… now have access to the fully automated RNAscope technology, providing pathologists with a powerful new tool to evaluate biomarkers involved in cancer, infection, and other important human diseases,” said Kim Kelderman , President, Diagnostics and Genomics Segment of Bio-Techne. “During these difficult times and ever-changing world due to COVID-19, we are excited about this innovative product as it delivers the benefit of improved workflow, reduced hands on time …

Square Mile of Defiance: WA Neighborhood Supports Itself During COVID-19 | 5/26/2020

… barter system has emerged for people to exchange what extras they have. When the local Duwamish River Cleanup Coalition/Technical Advisory Group teamed up with the University of Washington’s Interdisciplinary Center for Exposures, Diseases, Genomics , and Environment to translate pandemic health and safety guidelines into multiple languages, residents who spoke Somali, Khmer, Spanish, and Vietnamese stepped forward to create informational videos so their neighbors would have that critical information, too …

Global Gene Editing Service Market 2019-2025 | Top key players are Caribou Biosciences,GeneCopoeia,Editas Medicine,CRISPR Therapeutics,Genscript Biotech,Merck KGaA,Eurofins Genomics,Horizon Discovery,Thermo Fisher Scientific | 5/26/2020

… for making strategies to increase the market growth and effectiveness. Some of the companies competing in the Gene Editing Service Market are: Caribou Biosciences,GeneCopoeia,Editas Medicine,CRISPR Therapeutics,Genscript Biotech,Merck KGaA,Eurofins Genomics,Horizon Discovery,Thermo Fisher Scientific,Integrated DNA Technologies,SBS Genetech,DNA 2.0 (ATUM),Bio Basic,Gene Oracle,BBI Life Sciences,Genewiz Get Sample [email protected] https://www.reportsandmarkets.com/sample-request/global-gene-editing-service-market-2019 …

Inivata Announces Strategic Collaboration and Investment from NeoGenomics | Globe Newswire | 5/26/2020

Inivata Announces Strategic Collaboration and Investment from NeoGenomics NeoGenomics will commercialize Inivata’s InVisionFirst®-Lung liquid biopsy test in the United States Inivata and NeoGenomics to seek opportunities for collaboration with biopharmaceutical companies Equity investment in Inivata to support further development of leading liquid biopsy technology and products Research Triangle Park, NC, USA and Cambridge, UK, 26 May 2020 – Inivata, a leader in liquid biopsy, today announces the formation of a …

Next-generation Sequencing (NGS) Market – Latest Trends and Future Scope Report | BioSpace | 5/26/2020

Next Generation Sequencing (NGS) is utilized to execute different applications, for instance, biomarker revelation, oncology thinks about, customized solution, rural and creature research, and others. NGS has streamlined nucleotide investigation and has broadly supplanted customary instruments of genomics , particularly microarray effectively. The interest for NGS has expanded altogether inferable from surge in NGS applications and ascend in mechanical progressions in NGS. What’s more, the development in number of genome mapping …

Metabolomics Market is expected to be supported by the continuous technological advancements | BioSpace | 5/26/2020

… made in the sequencing of numerous organisms. Massive amounts were also earmarked for building analytical approaches to study various cell products, such as those from gene expression, metabolites, and proteins. All such approaches, namely genomics , proteomics, transcriptomics, and metabolomics are crucial tools used to comprehend an organism’s and its reaction to genetic perturbation or environmental stimuli. Metabolomics finds application in determining gene function, phenotyping of genetically modified plants and substantial …

NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test | The Wapakoneta Daily News | 5/26/2020

Highlights: NeoGenomics will commercialize the InVisionFirst-Lung liquid biopsy test in the United States NeoGenomics will establish a minority ownership position in Inivata, with an option to buy the entire company NeoGenomics will have a seat on the Inivata Board of Directors FORT MYERS, FL / ACCESSWIRE / May 26, 2020 / NeoGenomics, Inc. ( NASDAQ:NEO ) (the “ Company “ ), a leading provider of cancer-focused genetics testing services, announced today that it has formed …

Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak | 5/26/2020

… have also been described 7 , 8 . Infection occurs by exposure to rodent urine or feces or during preparation of the rodent for food. There have been advances in understanding the structural biology, immunology and genomics of LASV 2 , 9 , 10 , progress towards an immunotherapeutic drug 11 , 12 and new initiatives to develop a LF vaccine 13 . However, there is as yet no approved vaccine, and the only available treatment is …

Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting | PR Newswire | 5/26/2020

… pelareorep in early breast cancer ,” was co-authored by Dr. Prat Head of Medical Oncology at the Hospital Clínic of Barcelona , Associate Professor of the University of Barcelona and the Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute (IDIBAPS) along with several other colleagues from the academic cancer research group SOLTI, and institutions across North America and Europe …

Evogene Reports First Quarter 2020 Financial Results | PR Newswire | 5/26/2020

… and will facilitate clearer communications with potential partners and investors. This re-branding is the outcome of an evolution the company underwent in recent years that led Evogene to broaden its vision beyond plant genomics and focus on new target markets outside of agriculture. “Established as a spin-off from Compugen in 2002, Evogene was initially focused on applying its capabilities in computational biology in agriculture and more specifically, on …

The i2b2 tranSMART Foundation receives grant to advance research on the COVID-19 virus | PRWeb | 5/26/2020

… community in their quest to find methods to treat patients and prevent future infections of the COVID-19 virus.” The global COVID-19 research initiatives are focused on providing the following capabilities: tranSMART for Genomics Data and Analysis - within the next month, a public version of the tranSMART Platform v19 will be made available with existing public datasets of COVID-19, SARS and MERS genomics data. Research groups around the …

Compugen (NASDAQ:CGEN) Downgraded by Zacks Investment Research to “Hold” | Daily Political | 5/26/2020

lowered shares of Compugen (NASDAQ:CGEN) from a buy rating to a hold rating in a report published on Monday, Zacks.com reports. According to Zacks, “Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen’s expertise in these areas …

Genomics Bioinformatics Services Provider | 5/26/2020

Level : Others Subject : Bioinformatics You don’t need to Worry About your custom project because We are here to help you in full Custom Data Analysis. Below is the list of all genomics services we undertake: ✅MicroarrayDataAnalysis ✅NGS Data Analysis ✅Clinical Genomics Services ✅AgriGenomics Services ✅Bioinformatics Services For more information please visit website: http://www.arraygen.com/arraygen-services.php ✍1450 SUCCESS stories. ✍600 Projects Executed. ✍150 TB Data Analyzed. Related Education Ads in …

Aeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology | Globe Newswire | 5/26/2020

… more common neurological conditions, such as cerebral palsy, due to lack of awareness of this rare condition,” said George Diaz, M.D., Ph.D., division chief of medical genetics in the Division of Medical Genetics and Genomics and Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, New York, NY. “Because of the condition’s progressive nature, it is essential that patients be diagnosed early, and there …

Microbial matters: modelling the complex web of host–microbiome interactions | 5/26/2020

… much quicker and tackle the emergent complexity that arises.” Microbial chemistry gains fresh focus Thiele and her colleagues are developing mathematical and statistical approaches that use a range of data, from areas such as genomics and biochemistry, to reconstruct highly diverse gut microbial communities computationally. They capture only a fraction of the complex biological reality of the microbiome, but can reveal interactions between microbes and their hosts that would be …

Hygea and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnership | Globe Newswire | 5/26/2020

SAN FRANCISCO and SOUTH PLAINFIELD, N.J., May 26, 2020 (GLOBE NEWSWIRE) – Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare providers and patients to effectively manage genomic testing, and Admera Health, a premier precision medicine company and genetics laboratory, are pleased to announce a formal, agreed partnership. Eyal Odiz, CEO and Co-Founder of Hygea commented, “This important and strategic partnership will allow …

New lung cancer trial to help predict relapse | 5/26/2020

… will use personalised detection tests to look for the earliest signs of relapse in over 300 patients with lung cancer. The MERMAID-1 trial is a collaboration between the pharmaceutical company, AstraZeneca, and oncology genomics company, ArcherDX. Researchers will recruit around 330 patients with early-stage non-small cell lung cancer who have had their primary tumour removed in surgery across over 200 international hospital sites. The team will use …

Compugen (NASDAQ:CGEN) Downgraded by Zacks Investment Research to “Hold” - Ticker Report | 5/26/2020

Zacks Investment Research lowered shares of Compugen (NASDAQ:CGEN) from a buy rating to a hold rating in a report published on Monday, Zacks.com reports. According to Zacks, “Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen’s expertise …

Natera Announces New Prospera™ Data at ATC Showcasing Innovation in Cell-Free DNA | PR Newswire | 5/26/2020

… UCLA ) Trifecta Study: Calibrating Natera dd-cfDNA assay against the Molecular Microscope® Diagnostic System (MMDx) Speaker: Phil Halloran , MD, PhD; Professor, Department of Medicine, University of Alberta , Edmonton, Canada and Director, Alberta Transplant Applied Genomics Centre Prospera: Quantifying background cell-free DNA for enhanced performance Speaker: Phil Gauthier , MD, MBA; Medical Director of Organ Transplantation, Natera, Inc. “Natera has performed over two million cfDNA tests to date and has more …

Novagen Is Proud to Offer Top DNA Testing Services for The People of Vietnam | Markets Insider | Business Insider | 5/26/2020

HA NOI, Vietnam , May 26, 2020 /PRNewswire-PRWeb/ – The Novagen DNA testing center is built and developed by a team of experts with many years of experience in the fields of DNA Technology, Molecular Genetics, Genetic Analysis, Biochemistry, DNA Inspection, Genomics , Bioinformatics, Pharmaceuticals and Biomedical. The managing director of this center is Dr. Dang Tran Hoang , a doctorate graduate in biotechnology at the Kochi University of Technology from Japan , and …

Funding success for research into mental health and suicide prevention - UNSW Newsroom | 5/26/2020

… treatment. The project has potential to change practice, as well as to lead to clinical guidelines and a user-friendly pharmacogenomics support tool. This is a very exciting opportunity to leverage recent advances in genomics to improve the health outcomes of this vulnerable patient population. This project brings together a wide range of expertise with a vision to build a patient-centred mental health service, Doctor Kathy Wu said …

Clinical Research

Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients | BMJ | 4/1/2020

… ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients on behalf of Japan Gout Genomics Consortium (Japan Gout) 1 Department of Integrative Physiology and Bio-Nano Medicine , National Defense … Preventive Medicine, Faculty of Medicine , Saga University , Saga , Japan 18 Clinical Research Center , Saga University Hospital , Saga , Japan 19 Department of Preventive Medicine , Institute of Biomedical Sciences, Tokushima University Graduate School , Tokushima , Japan 20 Department …

Food and Drug Administration

Jennifer Doudna’s Berkeley institute launches COVID-19 testing lab | The Business Journals | 3/31/2020

… to run as many as 3,000 patient samples a day — has been established by star scientist Jennifer Doudna ‘s Innovative Genomics Institute. The lab will rely on samples from the University of California, Berkeley ‘s … the CRISPR gene-editing technology. The lab uses an established, Food and Drug Administration-approved polymerase chain reaction test, or PCR, but it is designed, with cooperation from the Chan Zuckerberg Biohub, to accelerate the …

Medical Research

Rationale and protocol for the 7- and 8-year longitudinal assessments of eye health in a cohort of young adults in the Raine Study | BMJ | 3/26/2020

Ophthalmology Protocol Rationale and protocol for the 7- and 8-year longitudinal assessments of eye health in a cohort of young adults in the Raine Study David A Mackey 1 , 4 1 Centre for Ophthalmology and Visual Science , University of Western Australia , Nedlands , Western Australia , Australia 2 Lions Eye Institute , Nedlands , Western Australia , Australia 3 Single Cell and Computational Genomics Lab , Garvan Institute of Medical Research , Darlinghurst , New South Wales …

Medicare

Natera Reports Fourth Quarter and Year 2019 Financial Results | PR Newswire | 2/26/2020

Genomics Co., Ltd. to commercialize NGS-based genetic assays for clinical use in China and select markets. Successfully completed initial key milestones. Entered into partnership to develop and commercialize personalized circulating tumor DNA monitoring assays with Foundation Medicine, Inc. Successfully completed initial key milestones. Received a positive draft local coverage decision from Medicare for reimbursement of Signatera™ in colorectal cancer. Launched the BESPOKE CRC study, a nationwide multi-center registry …

Precision Medicine

Advanced Medical Imaging, Genetic Analysis Could Improve Cancer Care | HealthIT Analytics | 2/3/2020

Precision Medicine News Advanced Medical Imaging, Genetic Analysis Could Improve Cancer Care Combining genetic analysis and advanced medical imaging could help providers understand how to best treat patients with cancer. Source: Thinkstock By February 03 … difficult. To improve brain cancer treatment, researchers from the Translational Genomics Research Institute (TGen) correlated the genetic and protein fingerprints of brain cancer cells with how those cells and surrounding cells looked using MRI. Currently …

Remote Monitoring

Precision Medicine in Primary Care: Bespoke. Genetic and Genomic. And Maybe Not Ready. | Managed Care Magazine | 1/30/2020

… genomic sequencing on the rise and patients having more say about their treatment, two hot areas—predictive genetic testing and pharmacogenomics—promise to extend “personalized” medicine beyond cancer care. But will this precision improve outcomes … genetic testing for the three CDC Tier 1 conditions and remote monitoring devices. Before the pilot, which ended in 2018, Stanford did not offer routine genetic testing in primary care. So far, that hasn’t changed …

Regenerative Medicine

Single-cell transcriptional diversity is a hallmark of developmental potential | 1/23/2020

… hallmark of developmental potential Gunsagar S. Gulati 1 , , Aaron M. Newman 1 , 8 , § 1 Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. 2 Department of Computer Science, Stanford University … These authors contributed equally to this work. ↵ † Present address: Color Genomics Inc., Burlingame, CA 94010, USA. ↵ ‡ Present address: Onena Medicine S.L., Donostia-San Sebastián, Guipúzcoa 20009, Spain. See all Hide authors and affiliations Science Vol …

Population Health

Genomics in healthcare: How systems are using the data and whether there is a cause for concern | Becker’s Hospital Review | 1/22/2020

Genomics certainly isn’t new to healthcare, although it is now becoming a larger part of a healthcare provider’s strategy to deliver the best care possible to patients. Several health systems across the country have entered … Jan. 10, Sioux Falls, S.D.-based Sanford Health partnered with population health company Color to scale the health system’s existing Imagenetics program, which has the goal of integrating genetic medicine into preventative care. Sanford will …

Advanced Primary Care

NorthShore Provides Clinical Genomic Testing to 10K Patients | HealthIT Analytics | 1/22/2020

NorthShore University HealthSystem and Color have completed the largest US genomics program to date, providing genomic results to 10,000 participants. Source: Getty Images By January 22, 2020 - NorthShore University HealthSystem and Color have delivered actionable … Cuts ED Visits by 42% “We’ve built a model of Advanced Primary Care that is transforming the delivery of healthcare,” said J.P. Gallagher, President and Chief Executive Officer of NorthShore. “We’ve seen firsthand that genetic …

Digital Health

Color News from JPM 2020 | 1/16/2020

… Conference 2020 this week, including a new funding announcement, a new partnership with Sanford Health, completion of the largest clinical genomics program with Northshore Health, awards from Fierce Healthcare and Rock Health, and a diabetes … Jeremy Sohn from Novartis. The conversation explored the definition of ‘digital health,’ the importance of data privacy, and where health technology will take us next. Population Genetics: Government and Private Endeavors Bear Fruit Our Chief …

NIH

Medical society asks DNA testing companies to share findings in public database: 4 things to know | Becker’s Hospital Review | 1/13/2020

The board of the American College of Medical Genetics and Genomics issued a statement on Jan. 12 calling on Myriad Genetics and other lab testing companies to share genetic testing data in a public database … to share their proprietary data and classification information in the NIH-funded ClinVar public database. “No company should put their interest above best patient care,” the medical group said in its statement, per WSJ . 3 …

Gut Microbiome

Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug–metabolite atlas | Nature | 1/13/2020

… gut microbiome). Cohort acknowledgements, ERF: we are grateful to all study participants and their relatives, general practitioners and neurologists for their contributions and to P. Veraart for her help in genealogy, J. Vergeer for supervision of the laboratory work and P. Snijders for his help in data collection. ERF was supported by the Consortium for Systems Biology (NCSB), both within the framework of the Netherlands Genomics Initiative (NGI)/NWO). The …

Diagnostic Imaging Market

Visiongain Report Offers Transformative Insights on the $4.9bn Liquid Biopsy Market | PR Newswire | 1/13/2020

… Astellas AstraZeneca Beckman Coulter Biocept, Inc. Bio-Rad Laboratories, Inc. BioReference Laboratories Biotime Blue Cross Blue Shield of Illinois Boreal Genomics Bristol- Myers Squibb Caris Life Sciences, Inc. Catalyst Pharmaceuticals CellMax Life Cerba HealthCare Cirina … Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029 Global Diagnostic Imaging Market Forecast 2019-2029 Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029 Global Cancer Immunotherapy Market Forecast 2019-2029 Checkpoint Inhibitors for Anti-Cancer Treatment …

Biotech

ABCT, Connecticut’s Newest Accelerator Program for Biosciences Ventures, Announces 2020 Cohort of Life Science Startups | PRWeb | 1/6/2020

… their capacity to revolutionize the life sciences industry. The 2020 ABCT cohort participants and ventures include: Abhijit Patel (Yale): Binary Genomics aims to develop and commercialize a blood test to enable early cancer detection via … genetic challenges affecting the skeletal system. Elizabeth Cusack (Independent): RBK Biotech has developed a nutritional product optimized for cancer care aimed at preventing and alleviating cancer related nutritional crisis and metabolically rooted treatment side effects …

Clinical Diagnostics

Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology | PR Newswire | 12/11/2019

Clinical Diagnostics group. Dr. Eterovic will lead the development and growth of oncology clinical diagnostic solutions to benefit our healthcare clients and their patients. Dr. Eterovic joins us from MD Anderson Cancer Center, where she was Associate Professor and Director of the Cancer Genomics Laboratory, as well as a driving force in the implementation of precision medicine at the prestigious institute; establishing a genomics laboratory for their NGS (Next Generation …

CRISPR

Biotech ETFs Hit New Highs on Deal Activities | Zacks | 12/10/2019

… 206.7 million in its asset base and has a Zacks ETF Rank 3 with a High risk outlook. Global X Genomics & Biotechnology ETF GNOM This is a new entrant in the space having accumulated $19.4 … daily volume of 4,000 shares (read: Genomics ETFs Surge on CRISPR’s Gene Editing Progress ). The Cancer Immunotherapy ETF ( CNCR - Free Report ) This ETF offers exposure to a basket of companies that develop therapies to treat …

Genomic Data Management

BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe | PR Newswire | 12/6/2019

ZURICH and BOSTON , Dec. 6, BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Life & Brain Genomics, a division of Life & Brain GmbH. Life & Brain Genomics is one of the leading European service providers for array-based omics analyses, supporting its customers from academia, industry and the healthcare sector with innovative products and scientific expertise from project planning to …

National Institutes of Health

The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD | 12/5/2019

… 410 triamcinolone and n=408 placebo arm). Of these participants, complete phenotypic information was available in 802 subjects (n=401 triamcinolone and n=401 placebo arm). LHS genotype data are available in the National Institutes of Health database for genotype and phenotype (dbGaP) under study accession phs000335.v3.p2. Genome-wide association testing We performed a genome-wide association study (GWAS) for the FEV 1 change rate (mL·year −1 …

Molecular Diagnostics

MolDX sets TruGraf® reimbursement level | Yahoo News | 12/5/2019

Reblog Most US kidney transplant recipients will now have coverage for the first non-invasive test that rules out “silent” sub-clinical rejection in patients with stable renal function MANSFIELD, Mass. , Dec. 5, 2019 /PRNewswire/ – Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics, today received notice that the Molecular Diagnostics Services (MolDX) Program developed by Palmetto …

Cancer Diagnostics

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… breaks down the revenue forecast for the global biomarkers market by Type: • Safety Biomarkers • Efficacy Biomarkers • Validation Biomarkers • This report also breaks down the revenue forecast for the global biomarkers market by Discipline: • Genomics • Proteomics • Bioinformatics • Other • This report also breaks down the revenue forecast for the global biomarkers market by Therapeutic Indication: • Cancer • Cardiovascular Diseases • CNS • Autoimmune Diseases • Other • This report provides individual revenue forecasts to 2029 for these …

Diagnostic Tests

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Biomarkers • Efficacy Biomarkers • Validation Biomarkers • This report also breaks down the revenue forecast for the global biomarkers market by Discipline: • Genomics • Proteomics • Bioinformatics • Other • This report also breaks down the revenue forecast for the global … 2019-2029 Global Precision Medicine Market Forecast 2019-2029 Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029 Global Protein Expression Market Forecast to 2029 SOURCE Visiongain …

Genomic Analysis

The Missing Link in Fighting Antibiotic Resistance | 12/4/2019

… and innovative technology that hits the market, health care data-sharing and surveillance systems also need to undergo extensive piloting before widespread adoption can occur. Companies at the forefront of the technology and genomics industries, however, are already shaking things up with pilot programs supported by major hospital systems and even state governments. In the fight against antibiotic-resistant superbugs, clinicians and decision makers have a responsibility to adhere to …

Medicaid

Science X Newsletter Tuesday, Dec 3 | 12/4/2019

… miscarriage, according to the study results published in Journal of Women’s Health. How to help fix the Centers for Medicare & Medicaid Services’ hospital rating system The current hospital star-rating system used by the U.S … gaining a better understanding of the whales’ lives. Researchers use genomics to discover potential new treatment for parasite disease Using innovative RNA sequencing techniques, researchers at the University of Maryland School of Medicine (UMSOM) Institute …

Wayne State University

Global Gynecology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | Globe Newswire | 12/4/2019

… Agency Avion Pharmaceuticals Aytu BioScience Back Bay Scientific Bavarian Nordic Bayer Bayer Healthcare Baylor College of Medicine Beckman Coulter Beijing Genomics Institute (BGI) Besins Healthcare Bill and Melinda Gates Foundation Biocon Biomnis Biotech Inc BL … Smith Vaccibody Valeo Pharma Vertical Pharmaceuticals Viramal Virtus Health VolitionRX Wayne State University Wellmed Windsor Pharmaceuticals Womens Choice Pharmaceuticals Wuxi Apptec Laboratory Services Xbrane Bioscience Xisle Pharma Ventures Trust ZenTech Zhengzhou University Zoetis For more …

RNA Sequencing

Science X Newsletter Tuesday, Dec 3 | 12/4/2019

genomics to discover potential new treatment for parasite disease Using innovative RNA sequencing techniques, researchers at the University of Maryland School of Medicine (UMSOM) Institute for Genome Sciences identified a promising novel treatment for lymphatic filariasis, a disabling parasitic disease that is difficult to treat. The potential new therapy is an experimental cancer drug called JQ1 and targets proteins found prominently in the worm’s genome; it appears to effectively kill …

Deep Genomics

Report: Startups could fuel the recovery of Canada’s economy | 4/29/2020

… Deep Genomics , Daisy Intelligence , Cyclica , and Dialogue that are either helping traditional businesses or are pivoting to help fight the pandemic. “The tech companies that provide these tools are already deeply entwined in every facet of the Canadian economy,” the report said. “Our supply chains, our just-in-time manufacturers, our retail sector and our energy sector are already highly dependent on innovative, essential and enabling tech companies,” it added …

Color Genomics

Bay Area coronavirus tests: Where can I get one? - SFChronicle.com | 4/29/2020

May 5-6: Gateway Plaza, 109 Plaza Dr., Vallejo For other locations and hours, go to https://carbonhealth.com/locations. • CityTestSF , a collaboration between the city of San Francisco, local tech companies and medical providers has two sites. Both are by appointment only. To schedule appointments, see www.sf.gov/citytestsf . One site, at Piers 30-32, is a drive-through site run by Carbon Health and Color Genomics and serves essential workers with symptoms …

Genentech

10x Genomics Appoints Kim Popovits to Board of Directors | Globe Newswire | 4/2/2020

Former Genomic Health CEO brings decades of healthcare experience to Board April 02, 2020 09:00 ET Source: 10x Genomics, Inc. PLEASANTON, Calif., April 02, 2020 (GLOBE NEWSWIRE) – 10x Genomics , Inc. (Nasdaq: TXG) today announced the … of countless patients during her time at Genomic Health and Genentech,” said Serge Saxonov, co-founder and CEO of 10x Genomics. “Today, more than ever, we need to enable scientists to make discoveries that will …

Exact Sciences

10x Genomics Appoints Kim Popovits to Board of Directors | Globe Newswire | 4/2/2020

Former Genomic Health CEO brings decades of healthcare experience to Board April 02, 2020 09:00 ET Source: 10x Genomics, Inc. PLEASANTON, Calif., April 02, 2020 (GLOBE NEWSWIRE) – 10x Genomics , Inc. (Nasdaq: TXG) today announced the … and optimal treatment of cancer, resulting in an acquisition by Exact Sciences (Nasdaq: EXAS) in November 2019. Prior to joining Genomic Health, Kim held several management roles at Genentech, Inc. including Senior Vice President of …

McKesson Corporation

INVO Bioscience Appoints Christopher Myer as VP Business Development - Americas | PR Newswire | 4/2/2020

Genomics Group at CooperSurgical, Inc., a leading woman’s healthcare provider. Most recently Mr. Myer was Director, Corporate Accounts and Strategic Relationships – North America ; and was previously Regional Sales Director, Fertility & Genomics Business Unit in the mid-Atlantic and Southeast region of the U.S. Mr. Myer also worked at leading medical device and capital equipment companies including Alliance Healthcare and McKesson Corporation. Mr. Myer holds a Bachelor of Science degree from …

Qiagen

Single Cell Sequencing Industry, Forecast to 2029: Expected to Grow at a Significant CAGR of 15.24% | PR Newswire | 4/1/2020

… decreasing dependence on trial and error medicine, analysis of gene expression level and protein expression level simultaneously through single cell genomics, the emergence of new sequencing techniques, and advancements in cell isolation techniques. However, there … LifeSciences, Illumina, Inc., Takara Bio , Inc., Perkin Elmer, and Inc. QIAGEN N.V., among others. Prominent Questions Answered What are the major market drivers, challenges, and opportunities in the global single cell sequencing market? What are …

Illumina

Single Cell Sequencing Industry, Forecast to 2029: Expected to Grow at a Significant CAGR of 15.24% | PR Newswire | 4/1/2020

… decreasing dependence on trial and error medicine, analysis of gene expression level and protein expression level simultaneously through single cell genomics, the emergence of new sequencing techniques, and advancements in cell isolation techniques. However, there … and Company, Celsee, Inc., BGI Genomics Co. Ltd. GE LifeSciences, Illumina, Inc., Takara Bio , Inc., Perkin Elmer, and Inc. QIAGEN N.V., among others. Prominent Questions Answered What are the major market drivers, challenges, and opportunities …

Amazon Health

Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility | Globe Newswire | 3/31/2020

Bionano Genomics, Rescale, Amazon Web Services, and Genoox are donating consumables and compute resources to this effort based in Hannover, Germany March 31, 2020 08:00 ET Source: Bionano Genomics SAN DIEGO, March 31, 2020 (GLOBE NEWSWIRE) – Bionano Genomics, Inc. (Nasdaq: BNGO) announced today the launch of the largest study to date aiming to identify genomic variants and novel active substances that influence resistance or sensitivity to the SARS-CoV2 virus …

Thermo Fisher

CRISPR pioneer Doudna opens lab to run Covid-19 tests | STAT | 3/30/2020

Genomics Institute, where Doudna is the executive director. It is being run by more than 50 volunteers from Berkeley and its environs, including the chief scientific officer of lab equipment giant Thermo Fisher, team members from Salesforce, the head of commercial at laboratory information analysis firm Third Wave Analytics, and workers from Hamilton Corp., a maker of laboratory robots, two of which are used in the laboratory. “It’s unbelievable to …

National Medical Products Administration

BGI’s Real-Time SARS-CoV-2 Test to Detect Novel Coronavirus Receives FDA Emergency Use Authorization | Markets Insider | Business Insider | 3/27/2020

CAMBRIDGE, Mass. , March 27, 2020 /PRNewswire/ – BGI Genomics Co. Ltd. (SZSE:300676) and its US subsidiary BGI Americas Corp. today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization … have developed diagnostic tests that received emergency approval from China’s National Medical Products Administration (NMPA) on January 26, 2020 , followed by CE-IVD marking on March 2 , 2020. BGI currently has a daily manufacturing capacity …

Pfizer

Response to: ‘Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis by Cutolo et al | BMJ | 3/19/2020

… Pfizer. KR has received research funding from Abbvie and Pfizer and honoraria/consultancy fees from Lilly, BMS,UCB, Pfizer, Janssen and Roche Chugai. JLM is currently funded by Roche Holding AG. BDM was partly supported by the SGC, which is a registered charity (number1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim,Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute (OGI-055 …

Novartis

Response to: ‘Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis by Cutolo et al | BMJ | 3/19/2020

Genomics Institute (OGI-055), Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant no. 115766), Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research,Innovation and Science (MRIS), Pfizer, Sao Paulo Research Foundation – FAPESP, Takeda and Wellcome (106169/ZZ14/Z). Patient consent for publication Not required. Provenance and peer review Commissioned; internally peer reviewed. Request Permissions If you wish to reuse any or all of this article …

Microsoft Health

Rescale Partners with Google Cloud and Microsoft Azure to Accelerate the Race for COVID-19 Vaccine with Cloud Supercomputers for Researchers | PR Newswire | 3/19/2020

PRNewswire/ – Rescale Inc., the leader in enterprise big compute, in cooperation with Google Cloud and Microsoft Azure, announced a new program today that immediately offers high performance computing resources (HPC) at no cost to teams … and devastating pandemic,” said Erik Holmlin , PhD, CEO of Bionano Genomics. “Bionano’s genome imaging technology can identify variation in genome structure better than any sequencing-based method, which makes us uniquely positioned to help identify …

Quest Diagnostics

Global Precision Medicine Market Review 2016-2019 and Forecast to 2026, Featuring Financials of Key Players | PR Newswire | 2/21/2020

Quest Diagnostics Incorporated, Qiagen, Pfizer, Novartis, Nanostring Technologies, Medtronic, Laboratory Corporation of America Holdings, Intomics, Hoffmann-La Roche, Ferrer inCode, Eagle Genomics, and Biocrates Life Sciences. Key Questions Answered in the Report How this market evolved since the year 2016 Market size estimations, forecasts and CAGR for all the segments presented in the scope Key Market Developments and financials of the key players Opportunity Analysis for the new entrants SWOT …

Medtronic

Global Precision Medicine Market Review 2016-2019 and Forecast to 2026, Featuring Financials of Key Players | PR Newswire | 2/21/2020

… Medtronic, Laboratory Corporation of America Holdings, Intomics, Hoffmann-La Roche, Ferrer inCode, Eagle Genomics, and Biocrates Life Sciences. Key Questions Answered in the Report How this market evolved since the year 2016 Market size estimations, forecasts and CAGR for all the segments presented in the scope Key Market Developments and financials of the key players Opportunity Analysis for the new entrants SWOT Analysis of the key players Fastest growing markets …

Teva Pharmaceutical

Global Precision Medicine Market Review 2016-2019 and Forecast to 2026, Featuring Financials of Key Players | PR Newswire | 2/21/2020

Teva Pharmaceutical Industries, Tepnel Pharma Services, Quest Diagnostics Incorporated, Qiagen, Pfizer, Novartis, Nanostring Technologies, Medtronic, Laboratory Corporation of America Holdings, Intomics, Hoffmann-La Roche, Ferrer inCode, Eagle Genomics, and Biocrates Life Sciences. Key Questions Answered in the Report How this market evolved since the year 2016 Market size estimations, forecasts and CAGR for all the segments presented in the scope Key Market Developments and financials of the key players Opportunity …

Teva Pharmaceutical

Global Precision Medicine Market Review 2016-2019 and Forecast to 2026, Featuring Financials of Key Players | PR Newswire | 2/21/2020

Teva Pharmaceutical Industries, Tepnel Pharma Services, Quest Diagnostics Incorporated, Qiagen, Pfizer, Novartis, Nanostring Technologies, Medtronic, Laboratory Corporation of America Holdings, Intomics, Hoffmann-La Roche, Ferrer inCode, Eagle Genomics, and Biocrates Life Sciences. Key Questions Answered in the Report How this market evolved since the year 2016 Market size estimations, forecasts and CAGR for all the segments presented in the scope Key Market Developments and financials of the key players Opportunity …

Johnson & Johnson

Arcturus Therapeutics to Present at Two Investor Conferences in March | Globe Newswire | 2/19/2020

… Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, CureVac AG, Synthetic Genomics Inc. and the Cystic Fibrosis Foundation. For more information visit www.Arcturusrx.com. Contact …

Myriad Genetics

Global at-Home Genetic Testing Market 2020 - Industry Analysis, Size, Share, Strategies and Forecast to 2026 | 2/7/2020

… Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes Key Players The various key company’s names, market shares, market revenue, outlook, market value, and …

SOPHiA Genetics

IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies | 1/16/2020

IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies IDT Partners With SOPHiA GENETICS to Increase Access to Clinical-grade Technologies Stocks News Feed CORALVILLE, Iowa–( BUSINESS WIRE )– Integrated DNA Technologies (IDT) , a leading comprehensive genomics solutions provider, announced an expanded global partnership with SOPHiA GENETICS, a leader in Data-Driven Medicine. Together, the superior enrichment products of IDT combined with SOPHiA GENETICS’s universal analytics platform and …

Apple Health

Health technology company Color scores $75M funding round to scale its infrastructure | FierceHealthcare | 1/16/2020

Health technology company Color scores $75M funding round to scale its infrastructure by Jan 16, 2020 12:24pm Burlingame, California-based Color is working to better integrate clinical-grade genomic testing into care. (Color) Health technology and precision genomics company Color has raised $75 million in a series D funding round led by T. Rowe Funds and Viking Global Investors. The Burlingame, California-based company counts Apple, Verily, Northshore University HealthSystem …

GSK

Consumers Should Control Their Data, and TimiHealth Blockchain Ecosystem Makes It Happen | PR Newswire | 1/15/2020

AUSTIN, Texas , Jan. 15, In the very near future TimiHealth will begin advancing consumer monetization of genomics data with a 70/30 split with the owners of the data. In simple terms, consumers will receive 70 … data to Calico Unknown Unknown 2018 - 23andMe sold data to GSK Unit quantity: 4,000,000 Price per unit: $75 Genomics data & Surveys (includes 4 year exclusive access to data) 2018 - Genomic Medicine Ireland sold data to …

Amgen

Consumers Should Control Their Data, and TimiHealth Blockchain Ecosystem Makes It Happen | PR Newswire | 1/15/2020

AUSTIN, Texas , Jan. 15, In the very near future TimiHealth will begin advancing consumer monetization of genomics data with a 70/30 split with the owners of the data. In simple terms, consumers will receive 70 … price per unit Data type 2012 - DECODE sold data to Amgen Unit quantity: 300,000 Price per unit: $1,383 Genomics data & Medical Records 2015 - 23andMe sold data to Genentech Unit quantity: 3,000 Price per unit: $20,000 …

Pathway Genomics

Visiongain Report Offers Transformative Insights on the $4.9bn Liquid Biopsy Market | PR Newswire | 1/13/2020

… Astellas AstraZeneca Beckman Coulter Biocept, Inc. Bio-Rad Laboratories, Inc. BioReference Laboratories Biotime Blue Cross Blue Shield of Illinois Boreal Genomics Bristol- Myers Squibb Caris Life Sciences, Inc. Catalyst Pharmaceuticals CellMax Life Cerba HealthCare Cirina … Novogene Co. Ltd. Oncocyte Corporation OncoMed Pharmaceuticals OPKO Health, Inc. Pathway Genomics PAXgene Permanente Medical Group Pfizer Priority Health QIAGEN N.V. Roche Holdings AG Silicon Biosystems SoftBank SouthGenetics, Inc. Stratose, Inc. Swift Biosciences, Inc. Synlab …

Biocept

Visiongain Report Offers Transformative Insights on the $4.9bn Liquid Biopsy Market | PR Newswire | 1/13/2020

… Turkey • Venezuela • Saudi Arabia • Republic of South Africa • Rest of LAMEA • Profiles of the selected leading companies: • Abbott • Beckman Coulter • Biocept, Inc. • Bio-Rad Laboratories • Biotime • Caris Lifesciences • F. Hoffman- La Roche • Guardant Health, Inc … BioReference Laboratories Biotime Blue Cross Blue Shield of Illinois Boreal Genomics Bristol- Myers Squibb Caris Life Sciences, Inc. Catalyst Pharmaceuticals CellMax Life Cerba HealthCare Cirina, Ltd. Clearbridge BioMedics Clinical Genomics Clovis Oncology CORE Diagnostics Daiichi …

NCI

In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees | Nature | 1/28/2020

NCI DCEG Cancer Genomics Research Laboratory Belynda D. Hicks 14 , Amy H. Hutchinson 14 , Michelle Manning 14 , Aurelie Vogt 14 , Kristine Jones 14 , Russell Williams 14 , Kedest Teshome 14 , Herb Higson 14 , Joseph Boland 14 , Sara Bass 14 , Bin Zhu 14 , Wen Luo 14 , Mingyi Wang 14 , Dongjing Wu 14 Author information These authors contributed equally: Alexander Pemov, Anand Pathak Affiliations Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics …

Rock Health

Color News from JPM 2020 | 1/16/2020

Color made a number of exciting announcements at the JP Morgan Healthcare Conference 2020 this week, including a new funding announcement, a new partnership with Sanford Health, completion of the largest clinical genomics program with Northshore Health, awards from Fierce Healthcare and Rock Health, and a diabetes analysis identifying at-risk populations. Our executive team also appeared on panels throughout the week, sharing insights about population genomics programs and building …

Morgan Stanley

Blueprint Medicines (NASDAQ:BPMC) Trading Down 7% | 12/5/2019

… shares were traded during mid-day trading. An increase of 121% from the average session volume of 459,888 shares. The stock had previously closed at $82.04. Several analysts recently commented on the company. Morgan Stanley cut their price objective on Blueprint Medicines from $110.00 to $109.00 and set an “overweight” rating for the company in a report on Friday, October 11th. Piper Jaffray Companies reissued a “hold” rating on shares …

Goldman Sachs

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… the company’s “toxic” environment. Since the scandal, Anthony Noto — former chief operating officer of Twitter and former managing director at Goldman Sachs — has taken over and shown interest in SoFi entering the cryptocurrency game . Scooter … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012 …

Alexandria Venture

No. 458: Ink flows, Whoppers sizzle and cyber-defenders rise – plus, a critical organoid donation | 12/4/2019

… genomics-based drug-discovery company, raised $39 million in Series A financing led by Leaps by Bayer and Novartis Venture Fund, with participation from Evotec, M Ventures, Alexandria Venture Investments and other institutional investors. + Genvid Technologies , a NYC-based developer of interactive streaming technologies for game developers, media companies and sports broadcasters, raised $27 million in Series B funding led by New York’s Galaxy Interactive, March Capital Partners, OCA Ventures …

Alexandria Venture Investments

No. 458: Ink flows, Whoppers sizzle and cyber-defenders rise – plus, a critical organoid donation | 12/4/2019

… genomics-based drug-discovery company, raised $39 million in Series A financing led by Leaps by Bayer and Novartis Venture Fund, with participation from Evotec, M Ventures, Alexandria Venture Investments and other institutional investors. + Genvid Technologies , a NYC-based developer of interactive streaming technologies for game developers, media companies and sports broadcasters, raised $27 million in Series B funding led by New York’s Galaxy Interactive, March Capital Partners, OCA Ventures …

C-Bridge Capital

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

Genomics Bioverativ Bleeding Disorders Foundation Blood Bank Of Delmarva Blood Centers of America Blood Systems Bluebird Bio BMG Pharmaceuticals Bonfils Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences CEI Celgene Central California Blood Center Cerus Cesca Therapeutics Children’s Hospital of Philadelphia Children’s Minnesota …

Flagship Pioneering

Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award | Markets Insider | Business Insider | 12/2/2019

CAMBRIDGE, Mass. , Dec. 2, 2019 /PRNewswire/ – Flagship Pioneering has announced the recipient of the firm’s annual Pioneering Leader Award. The 2019 award recognizes Nancy Simonian, M.D., CEO of Syros Pharmaceuticals (NASDAQ: SYRS), a company that … with the potential to address diseases that have eluded other genomics-based approaches,” said Dr. Simonian. “We are now advancing a deep pipeline of drug candidates, and what is particularly gratifying as we move our …

Bain Capital

#Squad Goals and the US Corporate Elites that Fund Them | 12/2/2019

… they represent. For Markey, in the current election cycle, that would be: Akin, Gump, et al.,[1] DLA Piper,[2] Bain Capital, Blackstone Group, Tufts University (alma mater of Anti-Defamation League CEO Jonathan Greenblatt … policy, Micah Shaffer; former Twitter executive Katie Jacobs Stanton, Color Genomics’ chief marketing officer; Anne Washington, a public policy professor at George Mason University who focuses on the social dynamics of information; and Whitney Wolfe …

Cinven

Dentons advises KKR and LGC on the sale of life sciences business | 12/2/2019

Cinven and Astorg. Financial terms of the transaction were not disclosed. LGC, which is headquartered near London and has over 3,200 employees across 22 countries, provides a comprehensive range of measurement tools, proficiency testing schemes, supply chain assurance standards and specialty genomics reagents underpinned by leading analytical and measurement science capabilities. Its scientific tools and solutions form an essential part of its customers’ quality assurance procedures and enable organisations to …

Atlas Venture

IFM Therapeutics Announces $55.5 Million Financing to Launch and Fund New Subsidiaries and Appointment of Dr. H. Martin Seidel as Chief Executive Officer | PR Newswire | 12/2/2019

… select targets of the innate immune system – Financing is led by new investor Omega Funds, with participation from existing investors Atlas Venture and Abingworth – Dr. Gary D. Glick to transition to role of executive chairman … Prior to that, Dr. Seidel was the head of NIBR’s Genomics Institute of the Novartis Research Foundation, where he helped advance more than 40 clinical candidates, among them four FDA-approved drugs. He has served …

Domain Associates

Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease? | 11/30/2019

Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by impairments in the cognitive domains associated with orientation, recording, and memory. This pathology results from an abnormal deposition of the β -amyloid (A β ) peptide and the intracellular accumulation of neurofibrillary tangles. Mitochondrial dysfunctions play an important role in the pathogenesis of AD, due to disturbances in the bioenergetic properties of cells. To date, the usual therapeutic drugs are limited because …

Citigroup

Weekly Investment Analysts’ Ratings Updates for Vanda Pharmaceuticals (VNDA) | 11/30/2019

… system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our … sell” rating. 11/7/2019 – Vanda Pharmaceuticals was downgraded by analysts at Citigroup Inc from a “buy” rating to a “neutral” rating. They now have a $19.00 price target on the stock. 11/7/2019 – Vanda Pharmaceuticals had its …

Venture Investors

Targeting Local Startup Excellence | 11/29/2019

… university IP, forming companies that it then connects to a network of corporate funders/buyers Centech’s platform is based on office space, programming, corporate access and a community of deep tech founders As venture investors, we are happy to see strong platforms generating unique companies that we can invest in. As a platform builder ourselves, the creativity of others pushes us to keep innovating and looking forward. 3. Ownership targets …

F-Prime Capital

Global RNAi Therapeutics Market 2019-2030: Focus on siRNA, miRNA, shRNA and DNA | PR Newswire | 11/27/2019

Genomics Eurogentec Exiqon Fidelity Biosciences FOCUS Media Jiangnanchun Foundation F-Prime Capital GeneCopoeia GeneCust GeneDesign GENEL Genentech GenePharma Genesis Pharmaceuticals Sanofi Genzyme / Genzyme Genomics England GlaxoSmithKline (GSK) Glycostem Therapeutics Goldman Sachs Gradalis Gritstone Oncology Guang’anmen Hospital of China Academy of Chinese Medical Sciences Harvard University Helmholtz Zentrum Mnchen Hercules Capital Histalim HuaKong Equity Investment Hugel Ildong Pharmaceutical Immunomedics INKEF Capital Institut national de la sant et de la recherche mdicale …

Foresite Capital

Genapsys Links $90 Million | 11/27/2019

… REDWOOD CITY — GenapSys Inc. , which is working on affordable DNA sequencing, has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate DNA sequencer ever developed … throughput system. “We are entering a multi-decade era of genomics that will revolutionize many industries, including healthcare diagnostics, pharmaceutical discovery, personalized medicine, food testing, forensics, agriculture, biology and beyond – but until now, we’ve lacked …

Jefferies Financial Group

Q1 2020 EPS Estimates for Agilent Technologies Inc Decreased by Jefferies Financial Group (NYSE:A) | 11/27/2019

Agilent Technologies Inc (NYSE:A) – Investment analysts at Jefferies Financial Group cut their Q1 2020 earnings per share estimates for Agilent Technologies in a research report issued on Tuesday, November 26th. Jefferies Financial Group analyst … through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems …

JP Morgan

FTSE 100 holding onto gains, Tesla and TD Ameritrade lead Nasdaq to new highs | 11/25/2019

… bound for most of next year,” the Goldman strategists said, alongside a prediction that the Federal Reserve will not cut interest rates in the coming year. In another Manhattan room, the sages at JP Morgan – Mystic Morg maybe? – have predicted 2020 might be the year of the next “great rotation” away from bond funds into equity funds, last seen in 2013. Back in Blighty, the Footsie has retreated slightly, now …

Piper Jaffray

NeuBase Therapeutics to Present at Upcoming Investor Conferences in December Nasdaq: NBSE | Globe Newswire | 11/25/2019

Evercore ISI HealthCONx Conference panel discussion at 12:30 p.m. ET on December 3 rd Piper Jaffray 31st Annual Healthcare Conference presentation at 8:30 a.m. ET on December 4 th PITTSBURGH, Nov. 25, 2019 (GLOBE NEWSWIRE) – NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, announced today that Dietrich Stephan, Chief Executive Officer of NeuBase, will participate in a …

Wellcome Trust

Returning incidental findings in African genomics research | Nature | 11/25/2019

Download references Acknowledgements This study was supported by the NIH Common Fund H3Africa Initiative award U54HG009790 to A.W. and J.D.V.; award U01 HG008226-01 to J.D.V.; Wellcome Trust/AAS ref. H3A/18/001 to A.W.; and US NIH awards U01HG009716 and U01HG007459, and NIH/NHLBI U24HL135600 to A.W. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Author information Department of …

Maxim Group

TrovaGene (NASDAQ:TROV) Releases Quarterly Earnings Results, Beats Estimates By $0.13 EPS | 11/23/2019

Maxim Group reiterated a “buy” rating and set a $6.00 target price on shares of TrovaGene in a research report on Thursday, October 3rd. About TrovaGene Trovagene, Inc, a clinical-stage, precision medicine oncology therapeutics company, develops oncology therapeutics for cancer care by leveraging its proprietary Precision Cancer Monitoring (PCM) technology in tumor genomics. Its lead drug candidate, PCM-075, is a Polo-like Kinase 1 selective adenosine triphosphate competitive …

SJF Ventures

Digital-health dollars are a disruptive force, but many investors stand to get burned | 11/21/2019

… is still seeking some type of exit, either through an IPO or M&A,” observed Cody Nystrom, managing director at SJF Ventures, a growth-stage venture fund. “A lot of that capital ultimately may not … led a $27 million series B funding round for clinical genomics informatics firm PierianDx. “This is how you metamorphosize the whole industry.” That said, many catalysts for digital health offer reasons for hope, if counterbalanced …

Rising Tide

A School-Based Intervention Using Health Mentors to Address Childhood Obesity by Strengthening School Wellness Policy | 11/21/2019

… the conclusions of recent systematic reviews conflict as to whether school-based programs can (10) or cannot (11) stem the rising tide of childhood obesity, there is consensus that schools cannot do it alone (12 … Irvine School of Medicine, Irvine, California. 10 Pediatric Exercise and Genomics Research Center (PERC), University of California, Irvine School of Medicine, Irvine, California. 11 Center for Translational Research, Children’s National Hospital, Washington, District of Columbia …

William Blair

Investment Analysts’ Recent Ratings Updates for EXACT Sciences (EXAS) | 11/20/2019

… buy” rating. They now have a $109.00 price target on the stock. According to Zacks, “EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer … EXACT Sciences had its “buy” rating reaffirmed by analysts at William Blair. 9/10/2019 – EXACT Sciences had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $135.00 price target on the stock …

Google Ventures

CB Insights - Digital Health 150: The Digital Health Startups Redefining The Healthcare Industry | 11/14/2019

… based in the UK. 2019 Digital Health 150 Unicorn Startups Company Category Country We Doctor Providers: Primary Care China GRAIL Genomics United States Oscar Health Insurance & Benefits United States Tempus Drug R&D: Real-World … of deals F-Prime Capital 31 New Enterprise Associates 30 Google Ventures 29 Venrock 28 Founders Fund 27 Khosla Ventures 27 GE Ventures 22 Social Capital 20 .406 Ventures 19 Andreessen Horowitz 18 Track all …

Mayo Clinic

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients | PR Newswire | 3/23/2020

… Mayo Clinic’s Windland Smith Rice Genetic Heart Rhythm Clinic and Sudden Death Genomics Laboratory. “In addition, the patient’s QTc can be obtained without exposing ECG technicians to affected patients which helps to conserve personal protection equipment (PPE) and thereby expand the capacity of our strained medical resources. We are encouraged by the progress being made by regulatory authorities in allowing us to rapidly respond to the COVID crisis.” Beginning in …

Baylor College of Medicine

Study to Advance Precision Medicine for Cardiovascular Disease | HealthIT Analytics | 3/18/2020

Precision Medicine News Study to Advance Precision Medicine for Cardiovascular Disease Researchers at Baylor College of Medicine will explore the role of genetics in cardiovascular disease, leading to enhanced precision medicine. Source: Thinkstock By March … study will be to provide personalized, preventive care , researchers stated. “Genomics has the potential to drive precision medicine. Some cardiovascular risk factors can be predicted or detected through genomic methods, making treatment options specific to …

Harvard Medical School

Dovetail Genomics Introduces New Dovetail™ Micro-C and HiChIP Kits | PR Newswire | 2/24/2020

SCOTTS VALLEY, Calif. Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced the global availability of its latest offerings, Dovetail™ Micro-C and HiChIP Kits. Dovetail Micro-C is the latest … critical biology questions.” Dr. David Sinclair , Professor of Genetics at Harvard Medical School and co-Director of the Paul F. Glenn Center for Biology of Aging Research, said “Now that we can sequence a genome …

Geisinger

Precision Medicine in Primary Care: Bespoke. Genetic and Genomic. And Maybe Not Ready. | Managed Care Magazine | 1/30/2020

… genomic sequencing on the rise and patients having more say about their treatment, two hot areas—predictive genetic testing and pharmacogenomics—promise to extend “personalized” medicine beyond cancer care. But will this precision improve outcomes … providers have started testing precision medicine beyond oncology. In 2018, Geisinger Health System in central Pennsylvania made a splash by announcing that it would add DNA sequencing to routine primary care. A small number of …

Geisinger Health System

Precision Medicine in Primary Care: Bespoke. Genetic and Genomic. And Maybe Not Ready. | Managed Care Magazine | 1/30/2020

… genomic sequencing on the rise and patients having more say about their treatment, two hot areas—predictive genetic testing and pharmacogenomics—promise to extend “personalized” medicine beyond cancer care. But will this precision improve outcomes … providers have started testing precision medicine beyond oncology. In 2018, Geisinger Health System in central Pennsylvania made a splash by announcing that it would add DNA sequencing to routine primary care. A small number of …

Kaiser Permanente

Liquid Biopsy & Other Non-Invasive Cancer Diagnostics Market, 2030 Outlook - Advances in Biotechnology have Enabled the Establishment of Several Minimally Invasive Approaches for Disease Diagnosis | Benzinga | 12/19/2019

… Andreessen Horowitz ANGLE Anixa Biosciences Annoroad Gene Technology Anpac Bio Anthill Ventures Apostle Arboretum Ventures ARCH Venture Partners ArcherDX ARNA Genomics Arquer Diagnostics ArrayGenomics Arrow Diagnostics Artiman Ventures ARUP Laboratories ASB Ventures Asia Genomics ASPiRA … Johnson Innovation Jointown Pharmaceutical Group JTS Health Partners Junson Capital Kaiser Permanente Ventures KEODES Kexin Capital LABLAB Laboratory for Advanced Medicine Lariat Biosciences Levine Cancer Institute Lexent Bio LifeArc LifeX Lilly Asia Ventures Limitless Earth …

Intermountain Healthcare

Intermountain Healthcare Selects PierianDx Clinical Genomics Solution | Business Wire | 12/11/2019

ST. LOUIS–(BUSINESS WIRE)–Dec 11, 2019– PierianDx, the leading clinical genomics informatics company, today announced that Intermountain Healthcare has selected the PierianDx Clinical Genomics Workstation to advance their precision medicine program, Intermountain Precision Genomics. Intermountain Healthcare will leverage PierianDx for next-generation sequencing (NGS) variant analysis, classification, and reporting services to assist in the identification of targeted therapies and potential clinical trial opportunities for cancer patients. PierianDx provides a …

MD Anderson Cancer Center

Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology | PR Newswire | 12/11/2019

… MD Anderson Cancer Center, where she was Associate Professor and Director of the Cancer Genomics Laboratory, as well as a driving force in the implementation of precision medicine at the prestigious institute; establishing a genomics laboratory for their NGS (Next Generation Sequencing) research projects, and enabling the discovery and identification of new biomarkers for personalized cancer care. Dr. Eterovic has authored many publications in high impact oncology journals, and holds …

Massachusetts General Hospital

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… Biomarkers • Efficacy Biomarkers • Validation Biomarkers • This report also breaks down the revenue forecast for the global biomarkers market by Discipline: • Genomics • Proteomics • Bioinformatics • Other • This report also breaks down the revenue forecast for the global … Consortium (ICGC) Les entreprises du médicament (LEEM) [ France ] Malmö University Massachusetts General Hospital Max Planck Institute for Molecular Genetics [ Germany ] National Academy of Sciences National Cancer Institute (NCI) [US] National Health Service (NHS) [UK] National …

Memorial Sloan Kettering Cancer Center

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market | PR Newswire | 12/4/2019

… breaks down the revenue forecast for the global biomarkers market by Type: • Safety Biomarkers • Efficacy Biomarkers • Validation Biomarkers • This report also breaks down the revenue forecast for the global biomarkers market by Discipline: • Genomics • Proteomics • Bioinformatics • Other • This report also breaks down the revenue forecast for the global biomarkers market by Therapeutic Indication: • Cancer • Cardiovascular Diseases • CNS • Autoimmune Diseases • Other • This report provides individual revenue forecasts to 2029 for these …

Hospital for Special Surgery

100 hospitals and health systems with great orthopedic programs | 2019 | Becker’s Hospital Review | 12/4/2019

… and reports a 1.4 percent complication rate for total hip and knee replacements, well below the 2.5 percent national average. Hospital for Special Surgery (New York City). Hospital for Special Surgery has been ranked the … joint implant wear testing and orthopedic stem cell research and genomics. Sentara Leigh Hospital (Norfolk, Va.). The Orthopedic Hospital at Sentara Leigh is an orthopedic specialty hospital offering the full continuum of care. The hospital’s …

Ascension

100 hospitals and health systems with great orthopedic programs | 2019 | Becker’s Hospital Review | 12/4/2019

… also cover athletic events throughout the state. Orthopaedic Hospital of Wisconsin (Glendale). Orthopaedic Hospital of Wisconsin is a member of Ascension Wisconsin and serves patients from across the state. Since being established in 2001 as … joint implant wear testing and orthopedic stem cell research and genomics. Sentara Leigh Hospital (Norfolk, Va.). The Orthopedic Hospital at Sentara Leigh is an orthopedic specialty hospital offering the full continuum of care. The hospital’s …

Vanderbilt University Medical Center

100 hospitals and health systems with great orthopedic programs | 2019 | Becker’s Hospital Review | 12/4/2019

… such as allograft transplantations for cartilage repair, joint implant design, joint implant wear testing and orthopedic stem cell research and genomics. Sentara Leigh Hospital (Norfolk, Va.). The Orthopedic Hospital at Sentara Leigh is an orthopedic … 50 hospitals in the nation for orthopedic surgery in 2018-19. Vanderbilt University Medical Center (Nashville, Tenn.) . With about 110,000 outpatient visits and 11,500 surgical cases performed annually, VUMC’s orthopedic department serves patients at 10 locations …

Cleveland Clinic

Cleveland Clinic awarded $2.8 million to study ecological, evolutionary contributors to cancer | 12/4/2019

Cleveland Clinic awarded $2.8 million to study ecological, evolutionary contributors to cancer Understanding interaction of these influences may lead to new treatment options Cleveland Clinic Print E-Mail Jacob Scott, M.D., Ph.D., a physician researcher from Cleveland Clinic’s Department of Translational Hematology and Oncology Research, recently received a $2.8 million grant from the National Cancer Institute, part of the National Institutes of Health, to study how ecological and evolutionary mechanisms …

Partners HealthCare

Global Hematology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies | PR Newswire | 12/4/2019

… College of Medicine Beijing Leadman Biochemistry Belgian Red Cross Bicycle Therapeutics Bill and Melinda Gates Foundation Biocept BIOCORP bioCSL Biogen BioMatrix Specialty Pharmacy Biomedical Advanced Research and Development Authority BioMedical Drug Development BioNano Genomics Bioverativ Bleeding Disorders Foundation Blood Bank Of Delmarva Blood Centers of America Blood Systems Bluebird Bio BMG Pharmaceuticals Bonfils Blood Center Boryung Pharmaceutical Bristol- Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech …

University of Texas MD Anderson Cancer Center

Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting | PR Newswire | 12/3/2019

… a list of studies that will be presented by GTC and its collaborators at ASH: 1) 2891-Title: “Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning” Collaborators: University of Texas MD Anderson Cancer Center, Houston, TX ; University of California, Irvine , CA; University Hospital Basel, Basel, Switzerland ; University of Verona , Verona , Italy ; Columbia University Medical Center, New York, NY ; Aalborg University Hospital, Aalborg, Denmark ; Well …

Columbia University Medical Center

Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting | PR Newswire | 12/3/2019

… Using Targeted NGS Expression Profiling and Deep Learning” Collaborators: University of Texas MD Anderson Cancer Center, Houston, TX ; University of California, Irvine , CA; University Hospital Basel, Basel, Switzerland ; University of Verona , Verona , Italy ; Columbia University Medical Center, New York, NY ; Aalborg University Hospital, Aalborg, Denmark ; Well Cornell Medical College, New York, NY ; Cleveland Clinic, Cleveland, OH ; San Raffaele Scientific Institute, Milano, Italy ; San Raffaele Hospital, Milan, Italy ; Odense University Hospital …

The University of Texas MD Anderson Cancer Center

Genomic Era Trials Drive Discovery | 12/2/2019

… would be to do molecularly driven basket and umbrella studies where each arm represents a molecular subtype,” said Timothy Yap, MBBS, PhD, MRCP, medical director of the Institute for Applied Cancer Science at The University of Texas MD Anderson Cancer Center in Houston …

Inova Health System

Inova takes steps to create personalized health ‘ecosystem’ | Virginia Business | 12/2/2019

… housing and hotels. Rendering courtesy Inova Center for Personalized Health On the former Exxon Mobil c ampus in Fairfax County, Inova Health System has plans for an “ecosystem” to develop health care startups and build … of the new research “will be centered around the Global Genomics and Bioinformatics Research Institute [GGBRI] and the potential treatments that arise from the research conducted.” GGBRI’s focus is on projects related to genetics, genomics …

Mount Sinai Health System

Top 10 AI in Healthcare Start-Ups in the UK - Cambridge Wireless | 12/2/2019

… being applied by innovative start-ups across a diverse range of health and social care services, from cancer diagnostics to genomics and mental health. With support from Government and industry, UK-based start-ups can … of Medicine at Mount Sinai (the medical school of the Mount Sinai Health System) is set to lead to product development and commercialisation by 2019. It is estimated that about 10% of men and 12 …

Northwell Health

New clues link genomic origins of memory impairment | PR Newswire | 12/2/2019

… of Medicine , with support from the Hearst Foundation, and under the guidance of Drs. Al-Abed and Huerta. About the Feinstein Institutes The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York . Home to 50 research labs, 2,500 clinical research studies and 4,000 researchers and staff, the Feinstein Institutes is raising the standard of medical innovation …

Sinai Health System

Top 10 AI in Healthcare Start-Ups in the UK - Cambridge Wireless | 12/2/2019

… being applied by innovative start-ups across a diverse range of health and social care services, from cancer diagnostics to genomics and mental health. With support from Government and industry, UK-based start-ups can … Medicine at Mount Sinai (the medical school of the Mount Sinai Health System) is set to lead to product development and commercialisation by 2019. It is estimated that about 10% of men and 12% of …

UT Southwestern Medical Center

Stem Cell Technology: The Only Constant Is Change | 12/2/2019

… being selected as one of Time magazine’s “50 Most Influential People in Health Care” in 2018. Other work by his laboratory has focused on wound healing and aging. Jun Wu, PhD, Assistant Professor, UT Southwestern Medical Center In collaboration with Jun Wu, PhD, assistant professor at UT Southwestern Medical Center and a former postdoc in the Belmonte laboratory, Izpisua Belmonte has established that models of early embryos can be generated …

Beth Israel Deaconess Medical Center

Clonal Selection Drives NF-{kappa}B Activation in Recurrent Nasopharyngeal Carcinoma | 12/2/2019

… Drives NF-κB Activation in Recurrent Nasopharyngeal Carcinoma Kartik Sehgal and David A. Barbie Kartik Sehgal Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts. This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below. Abstract Cancer genomic …

UPMC

Precision medicine, population health offer two sides to health improvement | Modern Healthcare | 11/30/2019

… Topol, director of the Scripps Research Translational Institute, which researches how to improve patient health by bringing together data like genomics and digital sensors. Today, “we just take from the trial, or the study, and … Medicine, a center jointly operated by GE Healthcare, Nokia and UPMC. However, based on health systems’ responses, KLAS Research and the Center for Connected Medicine categorized just 12% of their precision medicine programs as mature …

Oscar Health

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… likes — a move that some praised and others threatened to quit the app over. New York-based health insurance startup Oscar Health was founded in 2012 and is worth $3.2 billion. Mario Schlosser, CEO and … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012 …

30 companies worth at least $1 billion that didn’t exist 10 years ago | Markets Insider | Business Insider | 12/3/2019

… likes - a move that some praised and others threatened to quit the app over. New York-based health insurance startup Oscar Health was founded in 2012 and is worth $3.2 billion. Eduardo Munoz/Reuters Oscar … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. YouTube/Bloomberg Technology Launched in 2012, 10x Genomics went public in September after …

Health Net

UVM Health Network starts DNA testing program to find disease risks | 11/28/2019

BURLINGTON, Vt. (WCAX) A new pilot program at the University of Vermont Health Network is using genomic testing to determine if patients are at risk of certain diseases. The free DNA testing is only being done by one doctor with 10 patients right now, but more doctors are being added soon. It tests for 147 genes that are indicators of increased risk for certain diseases. “We want to take a …

DIRECTOR OF HEMATOPATHOLOGY | Nature | 11/21/2019

Burlington, VT, United States Posted about 5 hours ago Expires on January 03, 2020 The Department of Pathology and Laboratory Medicine of the Robert Larner, M.D. College of Medicine at the University of Vermont ( UVM ) and the University of Vermont Health Network seeks an academic hematopathologist to serve as Director of Hematopathology and the Medical Director of the Hematology section of the clinical laboratory. This is a full-time position …

Chan Zuckerberg

Jennifer Doudna’s Berkeley institute launches COVID-19 testing lab | The Business Journals | 3/31/2020

… to run as many as 3,000 patient samples a day — has been established by star scientist Jennifer Doudna ‘s Innovative Genomics Institute. The lab will rely on samples from the University of California, Berkeley ‘s … or PCR, but it is designed, with cooperation from the Chan Zuckerberg Biohub, to accelerate the testing process, including extraction and amplification of RNA. Processing samples because of lack of reagents or just sheer test …

Alex Azar

BGI’s RT-PCR SARS-CoV-2 Test to Detect Novel Coronavirus Now Commercially Available for Clinical Use in the United States | PR Newswire | 3/18/2020

CAMBRIDGE, Mass. , March 18, BGI Genomics. Co. Ltd. (SZSE:300676) and US subsidiary BGI Americas Corp., today announced that its Real-Time Fluorescent RT-PCR test for detecting SARS-CoV-2 is now commercially available … Human Services (HHS) declares a public health emergency. HHS Secretary Alex Azar declared an emergency for COVID-19 on January 31 . The test is only authorized for the duration of the declaration that circumstances exist …

Laura Wood

Worldwide Genomics Markets, 2020-2027 - Comprehensive Analysis on the $31.1 Billion-Projected Industry | PR Newswire | 2/26/2020

DUBLIN , Feb. 26, 2020 /PRNewswire/ – The “Genomics Market Size, Share & Trends Analysis Report by Application and Technology (Functional Genomics, Pathway Analysis), by Deliverables (Products, Services), by End Use, by Region, and Segment Forecasts, 2020 - 2027 … focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 …

George Church

Personal Genomics Pioneer George Church, PhD, to Keynote PEGS: The Essential Protein Engineering & Cell Therapy Summit | 2/25/2020

… George Church, who has had a profound influence on biotherapeutics, will share his perspective on the transformations and opportunities ahead,” said Christina (Tina) Lingham, Executive Director, Conferences and Fellow, CHI. Dr. Church, Professor of Genetics at Harvard Medical School, is known for pioneering personal genomics and synthetic biology, and developing the first methods for the first genome sequence. His presentation, “From Energy to Machine Learning,” will focus on new frontiers …

Francis deSouza

Is the Consumer DNA Fad Over? - Anthony Blumberg - Medium | 2/4/2020

… estimated the cuts would pare about 15% of the company’s staff. Some facts about 23andMe: is a privately held personal genomics and biotechnology company based in Sunnyvale, California is best known for providing a direct … to-consumer genetics market in its earnings call. Illumina CEO Francis deSouza noted to investors that his company is now taking a “cautious view” of the opportunity in the near term, referring to the market …

Emmanuelle Charpentier

ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding the Revocation of Broad Institute CRISPR Patent | Business Wire | 1/17/2020

DUBLIN- ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, announced that yesterday the European Patent Office’s (EPO) Technical Board of Appeal (Board) upheld the earlier EPO Opposition Division ruling that the Broad Institute patent EP2771468 is not formally entitled to a number of its asserted priority dates and all its claims are therefore not novel and …

Steve Jurvetson

Toronto-Based Deep Genomics Closes $40 Million In Funding | 1/17/2020

Toronto-based AI therapeutics company Deep Genomics announced it has raised $40 million in a new round of funding Toronto-based AI therapeutics company Deep Genomics announced it has raised $40 million in a new … companies seeking to change the world for the better,” added Steve Jurvetson, co-founder of Future Ventures and board member of Tesla and SpaceX. “Deep Genomics has pioneered a better way to systematically discover new …

Linda Avey

23andMe co-founder’s new startup, Precise.ly, brings genomics to India through Narayana partnerhsip | TechCrunch | 1/16/2020

Jonathan Shieber @jshieber / 9 hours Precise.ly , the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership with Naryana Health, one of India’s leading specialty hospital networks. Narayana, a company that operates a network of 24 hospitals serving 2.5 million patients, is one of the most fascinating stories in healthcare. By emphasizing …

Shahram Seyedin-Noor

23andMe co-founder’s new startup, Precise.ly, brings genomics to India through Narayana partnerhsip | TechCrunch | 1/16/2020

Jonathan Shieber @jshieber / 9 hours Precise.ly , the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership … investor in the company from, Civilization Ventures , and its founder Shahram Seyedin-Noor suggested that they begin to look globally for growth. “Precise.ly’s mission is to deliver validated genetic insights to the billions of people …

Melinda Gates

Liquid Biopsy & Other Non-Invasive Cancer Diagnostics Market, 2030 Outlook - Advances in Biotechnology have Enabled the Establishment of Several Minimally Invasive Approaches for Disease Diagnosis | Benzinga | 12/19/2019

Genomics Arquer Diagnostics ArrayGenomics Arrow Diagnostics Artiman Ventures ARUP Laboratories ASB Ventures Asia Genomics ASPiRA LABS AstraZeneca Astrimmune Asuragen Aurum Ventures AVIVA Biosciences Balderton Capital Bangkok Molecular Genetics BARD1 Life Sciences BeAble Capital BeaconLBS Bellwether Bio Best Med Opinion Beth Israel Deaconess Medical Center Betta Pharmaceuticals Bezos Expeditions BGI Genomics Bill & Melinda Gates Foundation Biocartis Biocept BioChain Biodesix BioDiscovery Bioeconomy Capital BioFluidica BIOHAL BioHisto Maroc Biolidics Biological Dynamics BioMarCare Technologies …

Matt Hancock

Is It Time To Let Out The Genetic Genie Out Of Its Bottle? | Forbes | 12/6/2019

Genomics has been playing a role within healthcare policy in the last month, with Matt Hancock, Secretary for Health and Socal Care in the U.K., announcing a “healthcare revolution”. But what role should genomics play in providing health and social care? As reported in the Daily Telegraph , Hancock confirmed that in the future tests would be “routinely offered” alongside standard checks on newborns as a way to identify any risk …

Bill Maris

Google co-founders Larry Page and Sergey Brin: a timeline of their rise and disappearance - The Verge | 12/5/2019

… company, through its Google Ventures investment arm, created Calico , a company effectively aimed at curing death. It’s headed up by Bill Maris, the founding partner of Google Ventures, who recruited former Genentech CEO Art Levinson … sister Anne Wojcicki, who was the founder and CEO of genomics company 23andMe. Rosenberg herself was publicly dating Android vice president Hugo Barra, who later moved to China to take a job with Xiaomi. The …

Donald Trump

Google co-founders Larry Page and Sergey Brin: a timeline of their rise and disappearance - The Verge | 12/5/2019

… while Brin was married to fellow Google employee Susan Wojcicki’s sister Anne Wojcicki, who was the founder and CEO of genomics company 23andMe. Rosenberg herself was publicly dating Android vice president Hugo Barra, who later … up in a personal capacity to a protest of President Donald Trump’s immigration-related executive order at San Francisco International Airport in January 2017; Brin is a Russian immigrant. That naturally made headlines , as did …

Fred Hutchinson

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012, 10x Genomics went public in September after hitting unicorn status in January. The company focuses on “single-cell sequencing” and has worked with institutions like Fred Hutchinson Cancer Research Center. In 2017, the company, backed by investors like Softbank , said its sales reached $71 million …

Jeff Bezos

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… giant Steve Madden . Allbirds recently called out Amazon’s own wool shoes, and CEO Joey Zwillinger penned an open letter to Jeff Bezos asking the company to “please steal our approach to sustainability.” As for the … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012 …

He Jiankui

‘Deliberate falsehood’: Scientists shred Chinese CRISPR babies experiment after leak of unpublished research | 12/4/2019

… ethics. The MIT Technology Review published portions of two previously unseen research papers on Tuesday, principally authored by Chinese biophysicist He Jiankui, who last year attempted to use CRISPR DNA editing technology to immunize twins … a deliberate falsehood,” Fyodor Urnov, a geneticist at the Innovative Genomics Institute, told the Technology Review. The study shows that the research team instead failed to reproduce the prevalent CCR5 variant. He’s claim that “embryo …

Masayoshi Son

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… Cofounder Adam Neumann proved to be so charming and persuasive that he secured a $4.4 billion investment from SoftBank CEO Masayoshi Son. But when WeWork publicly filed its IPO paperwork in 2019, the public got … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012 …

Bill Gates

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… better vegetarian burger fires up. Some noteworthy investors include pop singer Katy Perry, tennis star Serena Williams, and Microsoft cofounder Bill Gates. At the end of 2018, the company said it was turning out a … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012 …

Adam Neumann

30 companies worth at least $1 billion that didn’t exist 10 years ago | Business Insider | 12/4/2019

… society’s consciousness, it was called revolutionary. WeWork’s office spaces, sleek and full of amenities, attracted all kinds of members. Cofounder Adam Neumann proved to be so charming and persuasive that he secured a $4.4 billion … 3.6 billion when it went public, gene sequencing startup 10x Genomics continues to help doctors and scientists understand cancers and cell therapy. Serge Saxonov, cofounder & CEO of 10x Genomics. YouTube/Bloomberg Technology Launched in 2012 …

Mark Erlander

Trovagene Announces Data Showing Ability of Onvansertib to Rescue Venetoclax-Resistance in Acute Myeloid Leukemia (AML) | PR Newswire | 12/4/2019

… that onvansertib will be able to rescue AML patients once they develop resistance to frontline treatment with venetoclax,” said Dr. Mark Erlander , Chief Scientific Officer of Trovagene. “In our current Phase 2 AML trial, we … therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics. For more information, please visit https://www.trovageneoncology.com . Forward-Looking Statements Certain statements in this press release …

Tej Kohli

Investor Tej Kohli Expands ‘Venture Philanthropy’ Into 3d-printed Bionic Arms | 12/3/2019

The Tej Kohli Foundation is funding 3D-printed bionic arms for 10 British children from Bristol-based robotics pioneer Open Bionics. Open Bionics is building and developing the next generation of low-cost bionic limbs … and as a backer of high-impact AI, robotics and genomics ventures that have the potential to transform lives and change the world. He is also a major esports investor. Tej Kohli is a distinguished …

Francis Crick

Postdoctoral Training Fellow in Immunosurveillance – Hayday Laboratory | Nature | 12/3/2019

Postdoctoral Training Fellow in Immunosurveillance – Hayday Laboratory The Francis Crick Institute Posted about 2 hours ago Expires on January 06, 2020 Job title : Postdoctoral Training Fellow in Immunosurveillance – Hayday Laboratory Location: The Francis Crick Institute … adrian-hayday Research techniques used in the laboratory include functional genomics, flow cytometry, immunogenetics, tumour biology, and classical techniques of biochemistry and molecular biology. About us The Francis Crick Institute is a biomedical discovery institute …

Francis Collins

The Alliance of Genome Resources: Building a Modern Data Ecosystem for Model Organism Databases [Commentary] | 12/3/2019

… and have global impact. These resources also have been leveraged heavily by bioinformatics initiatives using comparative biology approaches for functional genomics, including MARRVEL (Model organism Aggregated Resources for Rare Variant ExpLoration) ( Wang et al. 2017 … Academy of Sciences. It was presented to the NIH Director, Francis Collins, at The Allied Genetics Conference (TAGC) in the summer of 2016 (Organizers of The Allied Genetics Conference 2016). As a follow-up to …

Patrick Soon-Shiong

NantKwest Announces Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients with Locally Advanced or Metastatic Solid Cancers | BioSpace | 12/3/2019

… antibodies has the potential to be transformative to the treatment of advanced solid tumors with cell-based therapies,” said Dr. Patrick Soon-Shiong, the Chairman and CEO of NantKwest. “PD-L1.t-haNK is a … in the United States. By leveraging an integrated and extensive genomics and transcriptomics discovery and development engine, together with a pipeline of multiple, clinical-stage, immuno-oncology programs, NantKwest’s goal is to transform medicine by …

Chuck Grassley

#Squad Goals and the US Corporate Elites that Fund Them | 12/2/2019

… National Republican Congressional and Senatorial Committees have received funds from Alphabet Inc. in this election cycle, as have individual candidates Chuck Grassley, Ben Sasse, Mike Lee, Mitch McConnell, Steve Scalise, Tim Scott, David Perdue, Liz … policy, Micah Shaffer; former Twitter executive Katie Jacobs Stanton, Color Genomics’ chief marketing officer; Anne Washington, a public policy professor at George Mason University who focuses on the social dynamics of information; and Whitney Wolfe …